Professor & Research Program Director
Division of Gynecologic Oncology
Department of Surgical Oncology
Roswell Park Cancer Institute

Co-Leader, Tumor Immunology and Immunotherapy Program
Roswell Park Cancer Institute

Dr. Kunle Odunsi joined the staff of Roswell Park Cancer Institute (RPCI) in 2001 as an Attending Surgeon in the Division of Gynecologic Oncology, Department of Surgical Oncology. Dr. Odunsi earned his medical degree from the University of Ife, Ile-Ife, Nigeria, in 1984. He completed postgraduate training in Obstetrics and Gynecology at the Rosie Maternity and Addenbrookes Hospitals, University of Cambridge, UK, leading to membership of the Royal College of Obstetricians and Gynecologists in 1991.

Dr. Odunsi completed a research fellowship in Molecular Oncology and earned his PhD at the Imperial Cancer Research Fund Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, UK. Subsequently, he completed residency training in Obstetrics & Gynecology at the Yale University School of Medicine, New Haven, CT, and clinical fellowship in Gynecologic Oncology at RPCI. He is a Fellow of the Royal College of Obstetricians and Gynaecologists in the United Kingdom. He is also a Fellow of the American College of Obstetricians and Gynecologists.

Dr. Odunsi is licensed by New York State and certified in Obstetrics & Gynecology by the American Board of Obstetrics and Gynecology. He is also board certified in the sub-specialty of Gynecologic Oncology.

Dr. Odunsi’s research interests include the molecular characterization of tumor antigens in ovarian cancer and their application to the development of vaccine therapies for the disease. He is the Co-Leader of the Tumor Immunology and Immunotherapy Program at Roswell Park Cancer Institute. He is also the Director of the United States’s Cancer Vaccine Collaborative Program of the Cancer Research Institute/Ludwig Institute for Cancer Research.

Dr. Odunsi is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, American Society for Reproductive Immunology, Association of African Biomedical Scientists, Cooperative Ovarian Cancer Group for Immunotherapy, Gynecologic Oncology Group, Society for Experimental Biology and Medicine, Society for Gynecologic Investigation, and the Society of Gynecologic Oncologists.

Dr. Odunsi has authored or co-authored over 100 journal publications, book chapters and abstracts. He also is an Ad Hoc Reviewer for the American Journal of Obstetrics and Gynecology, BMC Cancer, Cancer Immunity, Cancer Immunology Immunotherapy, Cancer Letters, Cancer Research, Clinical Cancer Research, Expert Opinion on Biological Therapy, Fertility and Sterility, Gynecologic Oncology, International Journal of Cancer, Journal of Clinical Pathology, Journal of the Society for Gynecologic Investigation, the Lancet, Molecular Cancer Therapeutics, Oncogene, Oncology and the Proceedings of the National Academy of Sciences, U.S.A.

Dr. Kunle Odunsi, MD, PhD